Table 1—

Estimates of prevalence and burden of newly diagnosed and known diabetes and IFG in the Iranian population aged 25–64 years

IFG*
Known diabetes
Newly diagnosed diabetes*
New and known diabetes*
BurdenPrevalence % (95% CI)BurdenPrevalence % (95% CI)BurdenPrevalence % (95% CI)BurdenPrevalence % (95% CI)
Age (years)
    25–341,217,45211.9 (11.2–12.5)102,6571.0 (0.8–1.1)201,6492.0 (1.7–2.2)311,9833.0 (2.7–3.4)
    35–441,336,70117.3 (16.6–18.1)248,5603.2 (3.0–3.5)269,7393.5 (3.2–3.8)519,1176.8 (6.3–7.3)
    45–541,070,89821.4 (20.6–22.2)368,9667.4 (7.0–7.8)294,2605.9 (5.5–6.3)629,20912.9 (12.3–13.5)
    55–64791,26624.3 (23.4–25.1)329,85010.1 (9.7–10.6)235,5647.2 (6.7–7.7)531,58016.8 (16.1–17.4)
Sex
    Men2,321,87017.4 (16.8–17.9)428,2753.2 (3.0–3.4)518,0943.9 (3.6–4.1)933,7997.1 (6.7–7.4)
    Women2,094,44716.3 (15.8–16.8)621,7594.8 (4.6–5.0)483,1183.8 (3.5–4.0)1,058,0908.3 (8.0–8.7)
Residential area§
    Rural1,143,04114.6 (14.0–15.1)217,7852.8 (2.6–3.0)237,3123.0 (2.8–3.3)442,1075.7 (5.3–6.0)
    Urban3,273,27617.8 (17.3–18.3)832,2494.5 (4.3–4.7)763,9004.2 (3.9–4.4)1,549,7828.6 (8.3–8.9)
Total national estimation4,416,31716.8 (16.4–17.2)1,050,0334.0 (3.9–4.1)1,001,2123.8 (3.6–4.0)1,991,8897.7 (7.5–7.9)
  • Data are n unless otherwise indicated.

  • * Based on participants’ laboratory results.

  • Standardized for sex and residential area.

  • Standardized for age and residential area.

  • § Adjusted for age and sex.

  • Weighted and standardized for age, sex, and residential area on the basis of the 2004 Iranian population.